Company Profile

ProPhase Labs (NASDAQ: PRPH) is a diversified medical science and technology company. The Company’s laboratory testing subsidiary, ProPhase Diagnostics, offers SARS-CoV-2 (COVID-19) and COVID-19 viral mutation PCR tests through both saliva and nasal swab methods at its CLIA certified laboratories. Critical to COVID testing, results are typically provided in under 24 hours. ProPhase Diagnostics also provides Respiratory Pathogen Panel (RPP) Molecular tests including Influenza A and B and others. ProPhase Labs researches, develops, manufactures, distributes, markets and sells OTC consumer healthcare products and dietary supplements, including dietary supplements under the TK Supplements® brand. The Company actively pursues strategic investments and acquisition opportunities for other companies, technologies and products.

View Profile

Latest Presentation

Industry Classifications

Sector:
Healthcare

Industry:
Drug Manufacturers

NAICS:
Pharmaceutical Preparation Manufacturing (325412)

SIC:
Pharmaceutical Preparations (2834)

Contact Information

Investor Relations
MZ Group - MZ North America
Chris Tyson
Managing Director
T: 949-491-8235
PRPH@mzgroup.us
www.mzgroup.us

Company Contact
ProPhase Labs, Inc.
711 Stewart Ave
Suite 200
Garden City, NY 11530